IV Iron Therapy Benefits Patients With Heart Failure, Severe Anemia, and Low TSAT
IRONMAN trial highlighted that anemia severity and TSAT < 20% are key indicators for identifying patients with heart failure who may benefit from intravenous iron therapy.
Read More